MedPath

Physostigmine

Generic Name
Physostigmine
Drug Type
Small Molecule
Chemical Formula
C15H21N3O2
CAS Number
57-47-6
Unique Ingredient Identifier
9U1VM840SP

Overview

A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity.

Background

A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity.

Indication

For the treatment of glaucoma, and in the treatment of severe anticholinergic toxicity.

Associated Conditions

  • Anticholinergic Syndrome

Clinical Trials

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath